Aubagio contains the active ingredient teriflunomide, a substance that acts on the immune system to limit it from attacking the nervous system. Aubagio is intended for the treatment of adults with relapsing-remitting multiple sclerosis, in order to reduce the frequency of relapses and to delay the progression of physical disability.
Reviews
There are no reviews yet.